Next-Generation Therapy for NK/T-cell lymphoma in East Asia: a multi-institutional retrospective study

Conditions

Extranodal NK/T-cell lymphoma, nasal type (ENKL)

Yuma Nato, Kana Miyazaki, Ayumi Fujimoto, Senzo Taguchi, Naoko Asano et al. (23 authors)

Blood2024-11-05

10.1182/blood-2024-198371

Incidence and Risk Factors of Central Nervous System Relapse in Localized Extranodal NK/T-Cell Lymphoma, Nasal Type: An Analysis of Nkea Study

Kana Miyazaki, Senzo Taguchi, Masahiko Oguchi, Ritsuro Suzuki, Naoko Asano et al. (19 authors)

Blood2018-11-291 citations

10.1182/blood-2018-99-115546

Early disease progression in patients (pts) with newly diagnosed localized nasal extranodal NK/T-cell lymphoma, nasal type (ENKL) treated with radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC).

Motoko Yamaguchi, Ritsuro Suzuki, Masahiko Oguchi, Naoko Asano, Kana Miyazaki et al. (21 authors)

Journal of Clinical Oncology2017-05-20

10.1200/jco.2017.35.15_suppl.7546

Outcomes and prognostic factors of radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC) for newly diagnosed, localized extranodal NK/T-cell lymphoma, nasal type (ENKL): a cooperative study in Japan.

Motoko Yamaguchi, Ritsuro Suzuki, Masahiko Oguchi, Naoko Asano, Jun Amaki et al. (21 authors)

Journal of Clinical Oncology2016-05-20

10.1200/jco.2016.34.15_suppl.7541

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with ENKL who were diagnosed between 2000 and 2013 in participating institutes

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Detailed information on treatment, clinical features and prognosis of patients with ENKL who were treated with next-generation therapy in Japan Construct a prognostic model among patients with ENKL who were treated with next-generation therapy	—

Secondary

Measure	Time frame
Toxicity profile of next-generation therapy in Japan Clinical features and prognosis of patients with ENKL who were diagnosed between 2000 and 2013 in Japan	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactMotoko Yamaguchi

Mie University Graduate School of Medicine Department of Hematology and Oncology

waniwani@clin.medic.mie-u.ac.jp+81-59-231-5016

Outcome results